awmsg logo



olodaterol (as hydrochloride) (Striverdi® Respimat®)


Reference No. 1537

Publication date:
13/01/2015


Appraisal information

olodaterol (as hydrochloride) (Striverdi® Respimat®) 2.5 mcg inhalation solution


Company: Boehringer Ingelheim Ltd
BNF category: Respiratory system
NMG meeting date: 15/10/2014
AWMSG meeting date: 12/11/2014
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 3614
Ministerial ratification: 09/01/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Olodaterol (as hydrochloride) (Striverdi® Respimat®) is recommended as an option for use within NHS Wales as a maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease (COPD).
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download